Sanders Calls Ozempic Pricing Totally Absurd, Seeks Meeting with Drugmaker Novo Nordisk

Senator Bernie Sanders wants to meet with the CEO of Novo Nordisk next week to discuss lowering the "totally absurd" and "outrageous" price of its drug Ozempic.

A study found Ozempic could be profitably manufactured for less than $5 per month's supply, yet it costs nearly $1,000 in the US.

Sanders said the high price of Ozempic will have a "deleterious impact" on Medicare, Medicaid, and private insurance budgets.

Sanders currently does not support legislation requiring Medicare to cover related obesity drugs like Wegovy at their current high prices.

State health plans and Medicaid offices are struggling with rising costs for Ozempic and Wegovy, raising sustainability questions.